Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
9.35
-0.42 (-4.30%)
Mar 31, 2025, 1:23 PM EDT - Market open
Tyra Biosciences Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Tyra Biosciences stock have an average target of 30.5, with a low estimate of 28 and a high estimate of 33. The average target predicts an increase of 226.20% from the current stock price of 9.35.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Tyra Biosciences stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 5 | 6 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +220.86% | Mar 31, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +220.86% | Feb 18, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +220.86% | Jan 13, 2025 |
UBS | UBS | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +199.47% | Jan 7, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $32 → $30 | Strong Buy | Maintains | $32 → $30 | +220.86% | Nov 11, 2024 |
Financial Forecast
Revenue This Year
n/a
from 416.19M
Revenue Next Year
n/a
EPS This Year
-2.08
from -1.51
EPS Next Year
-2.27
from -2.08
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | 5.1M | 42.0M | ||
Avg | n/a | 981,648 | 22.8M | ||
Low | n/a | n/a | 11.8M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | 4,178.5% | ||
Avg | - | - | 2,227.4% | ||
Low | - | - | 1,103.2% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -1.90 | -1.84 | -2.30 | ||
Avg | -2.08 | -2.27 | -2.27 | ||
Low | -2.17 | -2.70 | -2.21 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.